Simpson Thacher Adds Leading Antitrust and Competition Lawyer Antonio Bavasso
15.12.2020 11:00:00 EET | Business Wire | Press release
Simpson Thacher & Bartlett LLP announced today that Antonio Bavasso will join the Firm’s London office, where he will be a Partner in the Antitrust and Trade Regulation Practice.
Antonio is widely recognized as a leading lawyer in antitrust and regulation, with more than twenty years of experience in some of the most high-profile and precedent-setting merger, behavioural and litigation cases internationally. He advises clients across a broad range of industries, including the technology, media and telecom sectors, in a wide variety of matters before the European Commission, the United Kingdom Competition and Markets Authority and other global competition authorities.
“Antonio has extensive experience that is relevant to our clients, having advised on the antitrust aspects of some of the most high-profile transactions in recent years. That experience will further enhance our ability to provide clients operating across Europe with top-tier advice in both tackling complex transactions and in navigating the enforcement landscape,” said Bill Dougherty, Chairman of Simpson Thacher’s Executive Committee. “We are very pleased to welcome him to the Firm.”
Simpson Thacher’s Antitrust and Trade Regulation Practice advises companies across every major industry on their global antitrust and competition needs, as well as on regulatory issues impacting their interests and operations around the world. The Firm counsels clients on the full array of antitrust enforcement, litigation and investigation issues—from cartel and other anticompetitive activity to litigation of private antitrust actions—as well as regulatory and compliance matters related to cross-border activities such as trade regulation and economic sanctions.
“Antonio is known throughout the market for his superb judgment and ability to provide clients with insightful and practical advice on high-profile, cross-border transactions, as well as in complex antitrust litigation and enforcement matters. This diversity of experience makes him a natural fit for Simpson Thacher and a wonderful addition to both our global M&A and Antitrust and Trade Regulation Practices, and sets the stage for the further expansion of our European antitrust and competition practice,” said David Vann, Head of Antitrust for Europe and Asia at Simpson Thacher.
“Given the sophistication and versatility of his experience, Antonio will deliver tremendous value to our clients and is an excellent addition to our outstanding group of lawyers in London,” added Jason Glover, Managing Partner of the Firm’s London Office. “Along with our recent promotion of Étienne Renaudeau to Partner, we expect David, Antonio and Étienne to spearhead the future growth of our European antitrust practice.”
Antonio joins the Firm from Allen & Overy LLP, where he was Co-Head of the Global Antitrust Practice and Co-Head of the Telecoms, Media and Technology Practice. He is both U.K. and Italy-qualified. He received his J.D., magna cum laude, from the University of Florence and a Ph.D. from University College London, where he is a visiting professor and Co-Founder and Co-Director of the Jevons Institute for Competition Law and Economics. Antonio is also a non-governmental adviser on unilateral practices and merger control for the International Competition Network of competition authorities.
ABOUT SIMPSON THACHER
Simpson Thacher & Bartlett LLP (www.simpsonthacher.com) is one of the world’s leading international law firms. The Firm was established in 1884 and has more than 1,000 lawyers. Headquartered in New York with offices in Beijing, Hong Kong, Houston, London, Los Angeles, Palo Alto, São Paulo, Tokyo and Washington, D.C., the Firm provides coordinated legal advice and transactional capability to clients around the globe.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20201215005258/en/
Contact information
Media:
Caroline Fatchett
Simpson Thacher
Assoc. Director, Communications
Caroline.Fatchett@stblaw.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
VeriSilicon Enhanced ISP8200-FS Series IP Achieves ASIL B Functional Safety Certification5.2.2026 02:00:00 EET | Press release
VeriSilicon (688521.SH) today announced its latest enhanced versions of Image Signal Processing (ISP) IP ISP8200-FS series, ISP8200-ES and ISP8200L-ES, featuring improved performance and energy efficiency to better support complex automotive camera systems. These enhanced IPs have successfully achieved ISO 26262 ASIL B functional safety certifications issued by TÜV NORD, an international inspection and certification institution, further validating their suitability and reliability for ADAS and autonomous driving applications. The latest enhanced ISP8200-FS series IP can operate at up to 1.2 GHz and support data processing from up to 16 image sensors. It significantly improves the performance of multi-camera scheduling, enabling flexible data-access capabilities and efficient hardware pipeline utilization for automotive camera systems. The enhanced series IP integrates image processing technologies including Color Noise Reduction (CNR) and radial Lens Shading Correction (LSC), and featu
Mainstay Medical Announces Exclusive Coverage of ReActiv8® by Blue Cross Blue Shield of North Dakota4.2.2026 23:30:00 EET | Press release
Mainstay Medical Holdings plc today announced that Blue Cross Blue Shield of North Dakota has established favorable coverage for the company’s ReActiv8 Restorative NeurostimulationTM therapy for the treatment of intractable chronic low back pain. The policy went into effect in January 2026 and specifies that ReActiv8 is the only therapy considered medically necessary by the policy when the conditions for coverage are met. “We are pleased that another Blue Cross Blue Shield payer has joined Anthem in making ReActiv8 available to well-selected patients after reviewing the large body of clinical evidence we have built,”said Jason Hannon, CEO of Mainstay Medical. “Patients with intractable chronic low back pain are desperately seeking durable solutions, and ReActiv8 has proven to be a safe and effective solution through six clinical studies with 633 patients treated and 1,950 patient-years of follow-up, including two multi-center, randomized controlled clinical studies. We look forward to
Kinaxis Inc. to Host Fourth Quarter 2025 Financial Results Conference Call on March 5, 20264.2.2026 23:30:00 EET | Press release
Kinaxis® Inc. (TSX:KXS), a global leader in supply chain orchestration, today announced that it has scheduled its conference call to discuss the financial results for its fourth quarter and year ended December 31, 2025. The call will be hosted on Thursday, March 5 at 8:30 a.m. Eastern Time by Razat Gaurav, chief executive officer, and Blaine Fitzgerald, chief financial officer, followed by a question and answer period. The Company will report its financial results for the fourth quarter and year after the close of markets on Wednesday, March 4, 2026. CONFERENCE CALL DETAILS DATE: Thursday, March 5, 2026 TIME: 8:30 a.m. Eastern Time WEBCAST: https://events.q4inc.com/attendee/567578009 (available for three months) About Kinaxis Kinaxis is a leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them. Our powerful, AI-infused supply chain orchestration platform, Maestro, combines proprietary technologies and techniques that
Multi-Color Corporation Receives Court Approval of First Day Motions4.2.2026 22:30:00 EET | Press release
Multi-Color Corporation (“MCC” or the “Company”), a global leader in prime label solutions, today announced that it has received approval from the U.S. Bankruptcy Court for the District of New Jersey (the “Court”) for first day relief related to its prepackaged Chapter 11 filed on January 29, 2026. The approved relief affirms that the Company will operate in the normal course, pay all trade vendors and suppliers in full, and maintain a strong liquidity position during the restructuring. As part of this relief, the Court granted MCC immediate access to $125 million of $250 million in debtor-in-possession (“DIP”) new money financing, provided by certain holders of MCC’s secured first lien debt and its equity sponsor, CD&R. This funding will capitalize the business through the initial stages of the prepackaged Chapter 11 process. The Court also granted MCC authority to pay trade vendors and suppliers in full in the ordinary course, maintain wages and benefits without interruption, satisfy
InterSystems Honored with Four 2026 Best in KLAS Awards4.2.2026 19:00:00 EET | Press release
InterSystems, a creative data technology provider powering more than one billion health records globally, today announced it has received four Global 2026 Best in KLAS awards. The company earned a #1 ranking for Acute Care EHR in Asia, Oceania, and France, as well as for Shared Care Records in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260204241673/en/ InterSystems earns four Best in KLAS awards for 2026 Best in KLAS is KLAS Research’s annual recognition of top-performing healthcare technology and services solutions, based entirely on feedback from healthcare provider organizations. Awards are given within defined software and services market segments evaluated by KLAS Research using a standardized methodology that reflects customer experience and performance. In addition to U.S. market segments, KLAS also recognizes top-performing solutions through its Global (Non-U.S.) Best in KLAS Awards, which are based on fe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
